Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Matrix inhibitor

Positive-Tone Photoresists based on Dissolution Inhibition by Diazonaphthoquinones. The intrinsic limitations of bis-azide—cycHzed mbber resist systems led the semiconductor industry to shift to a class of imaging materials based on diazonaphthoquinone (DNQ) photosensitizers. Both the chemistry and the imaging mechanism of these resists (Fig. 10) differ in fundamental ways from those described thus far (23). The DNQ acts as a dissolution inhibitor for the matrix resin, a low molecular weight condensation product of formaldehyde and cresol isomers known as novolac (24). The phenoHc stmcture renders the novolac polymer weakly acidic, and readily soluble in aqueous alkaline solutions. In admixture with an appropriate DNQ the polymer s dissolution rate is sharply decreased. Photolysis causes the DNQ to undergo a multistep reaction sequence, ultimately forming a base-soluble carboxyHc acid which does not inhibit film dissolution. Immersion of a pattemwise-exposed film of the resist in an aqueous solution of hydroxide ion leads to rapid dissolution of the exposed areas and only very slow dissolution of unexposed regions. In contrast with crosslinking resists, the film solubiHty is controUed by chemical and polarity differences rather than molecular size. [Pg.118]

Sample pre-treatment. Novel procedures of electrochemical sample treatment have been proposed to decrease the signal interference with native cholinesterase inhibitors present in fruits and vegetables. Polyphenolic compounds were removed by electrolysis with soluble A1 anode followed by the oxidation of thionic pesticides with electrogenerated chlorine. The procedure proposed makes it possible to decrease the background current and the matrix effect by 80-90%. Thus, the detection limits of about 5 ppb of Pai athion-Methyl and Chloropyrifos-Methyl were obtained in spiked grape juice without any additional sepai ation or pre-concentration stages. [Pg.295]

Design and therapeutic application of matrix metalloproteinase heterocyclic inhibitors 99CRV2735. [Pg.232]

Morgunova E, Tuuttila A, Bergmann U et al (2002) Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2. Proc Natl Acad Sci USA 99 7414—7419... [Pg.748]

The matrix metalloproteinases are inhibited by specific endogenous tissue inhibitor of metalloproteinases (TIMPs), which comprise a family of four protease inhibitors TIMP-1, TIMP-2, TIMP-3, and TIMP-4. Overall, all MMPs are inhibited by TIMPs once they are activated but the gelatinases (MMP-2 and MMP-9) can form complexes with TIMPs when the enzymes are in the latent form. [Pg.1201]

Gelman BB, Wolf DA, Rodriguez-Wolf M et al (1997) Mononuclear phagocyte hydrolytic enzyme activity associated with cerebral HIV-1 infection. Am J Pathol 151 1437-1446 Giraudon P, Buart S, Bernard A et al (1997) Cytokines secreted by gUal cells infected with HTLV-I modulate the expression of matrix metalloproteinases (MMPs) and their natural inhibitor (TIMPs) possible involvement in neurodegenerative processes. Mol Psychiatry 2(107-10) 84... [Pg.168]

Miyasaki KT, Wilson ME, Brunetti AJ, Genco RJ (1986) Oxidative and nonoxidative killing of actinobacillus actinomycetemcomitans by human neutrophils. Infect Immun 53(1) 154—160 Moore K (1999) CeU biology of chronic wounds the role of inflammation. J Wound Care 8(7) 345-348 Moses MA (1997) The regulation of neovascularization of matrix metaUoproteinases and their inhibitors. Stem Cells 15(3) 180-189... [Pg.350]

GOTO T, MAEDA H and TANAKA T (2002) A Selective inhibitor of matrix metalloproteinases inhibits the migration of isolated osteoclasts by increasing the life span of podosomes. J Bone Miner Metab. 20 (2) 98-105. [Pg.214]

Methylanaline could be transnitrosated with nitrite and S-nitrosocysteine and also by a simulated protein bound nitrite. In the latter case, an important factor was the local concentration of nitrosothiol groups on the matrix. The effects of S-nitrosocysteine as an inhibitor of lipid oxidation, as a color developer, and as an anticlostridial, have been reported recently in a turkey product (31). The Molar concentration of RSNO equating to 25 ppm nitrite gave similar results for color and inhibition of lipid oxidation but had less anti-clostridial activity. Transnitrosation between RSNO and heme protein was demonstrated. [Pg.296]

A fully automated instrumental procedure has been developed for analyzing residual corrosion inhibitors in production waters in the field. The method uses ultraviolet (UV) and fluorescence spectrophotometric techniques to characterize different types of corrosion inhibitors. Laboratory evaluations showed that fluorescence is more suitable for field application because errors from high salinity, contamination, and matrix effect are minimized in fluorescence analysis. Comparison of the automated fluorescence technique with the classic extraction-dye transfer technique showed definite advantages of the former with respect to ease, speed, accuracy, and precision [1658],... [Pg.86]

An amido-amine (e.g., from the reaction of tetraethylenepentamine with stearic acid) is modified with propylene oxide [792]. The product is dispersed in a polymer matrix such as an acrylic or methacrylic polymer. The inhibitor is slowly released into the surrounding environment, such as in an oil or gas well, to prevent corrosion of metal equipment in the well. [Pg.91]

More recently, screening efforts at Novartis have identified a hydroxamic acid containing a benzothiazinone ring system (32) [108]. This inhibitor is very potent versus S. aureus Ni -PDF (<5nM) and displays good selectivity versus matrix metalloprotease-2 (MMP-2) and MMP-13. Unfortunately (32), and all other analogues prepared, such as carbon isosteres (33), sulfones (34), N-substituted analogues (35) and N-formyl-N-hydroxylamines (36), lacked appreciable antibacterial activity in spite of their potent enzyme inhibitory activity. Further studies performed by Novartis suggest that these molecules are unable to penetrate the outer cell membrane of E. coli, and may bind to the cell membrane of S. aureus [108]. [Pg.131]

Several aryl esters of 6-chloromethyl-2-oxo-2//-l -benzopyran-3-carboxylic acid act as human Lon protease inhibitors (alternate substrate inhibitors)46 without having any effect on the 20S proteasome. Proteasomes are the major agents of protein turnover and the breakdown of oxidized proteins in the cytosol and nucleus of eukaryotic cells,47 whereas Lon protease seems to play a major role in the elimination of oxidatively modified proteins in the mitochondrial matrix. The coumarin derivatives are potentially useful tools for investigating the various biological roles of Lon protease without interfering with the proteasome inhibition. [Pg.368]

Fig. 3 The SAR by NMR approach. Example of a small bidentate molecule designed using this approach. The example shown is for the design of a potent inhibitors of the matrix metalloproteinase MMP3. (a) Docked structures of the identified fragment leads are shown with cyan carbons, whereas the linked compound is shown with green carbon atoms. All structures were experimentally determined by NMR. (b) Chemical structures (and in vitro potencies) of the fragment leads and subsequent high-affinity linked compounds. Adapted from [7]... Fig. 3 The SAR by NMR approach. Example of a small bidentate molecule designed using this approach. The example shown is for the design of a potent inhibitors of the matrix metalloproteinase MMP3. (a) Docked structures of the identified fragment leads are shown with cyan carbons, whereas the linked compound is shown with green carbon atoms. All structures were experimentally determined by NMR. (b) Chemical structures (and in vitro potencies) of the fragment leads and subsequent high-affinity linked compounds. Adapted from [7]...

See other pages where Matrix inhibitor is mentioned: [Pg.3068]    [Pg.494]    [Pg.747]    [Pg.126]    [Pg.168]    [Pg.362]    [Pg.479]    [Pg.18]    [Pg.25]    [Pg.501]    [Pg.640]    [Pg.53]    [Pg.220]    [Pg.83]    [Pg.87]    [Pg.363]    [Pg.866]    [Pg.888]    [Pg.1027]    [Pg.210]    [Pg.125]    [Pg.138]    [Pg.382]    [Pg.23]    [Pg.605]    [Pg.623]    [Pg.624]    [Pg.155]    [Pg.154]    [Pg.168]    [Pg.171]    [Pg.350]    [Pg.430]    [Pg.80]    [Pg.660]    [Pg.45]    [Pg.387]   
See also in sourсe #XX -- [ Pg.70 ]




SEARCH



Inhibitor, Matrix Metalloproteinase development

Matrix metalloprotease inhibitors

Matrix metalloprotease inhibitors binding

Matrix metalloprotease inhibitors design

Matrix metalloproteinase inhibitor

Matrix metalloproteinase inhibitors MMPIs)

Matrix metalloproteinase inhibitors binding

Matrix metalloproteinase inhibitors design

Matrix metalloproteinase inhibitors formation

Matrix metalloproteinase inhibitors functional groups

Matrix metalloproteinase inhibitors, for

Matrix metalloproteinases inhibitors

Tissue inhibitor of matrix metalloproteinases

© 2024 chempedia.info